127 related articles for article (PubMed ID: 17536276)
1. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
Cui LY; Li YF; Li YH; Zhang JB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276
[TBL] [Abstract][Full Text] [Related]
2. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
3. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
[TBL] [Abstract][Full Text] [Related]
4. [Thymus CT scan and thymoma associated antibodies in myasthenia gravis with thymoma].
Li YF; Li YH; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):517-9. PubMed ID: 16995304
[TBL] [Abstract][Full Text] [Related]
5. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
Suzuki S
Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity against the ryanodine receptor in myasthenia gravis.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
[TBL] [Abstract][Full Text] [Related]
7. [Anti-ryanodine receptor antibody and the thymus gland in myasthenia gravis].
Iwasa K; Asaka T; Takamori M
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):655-63. PubMed ID: 9627474
[No Abstract] [Full Text] [Related]
8. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Ann N Y Acad Sci; 1998 May; 841():530-3. PubMed ID: 9668288
[No Abstract] [Full Text] [Related]
10. [Serum anti-titin antibody in patients with myasthenia gravis].
Li YF; Zhang JB; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
[TBL] [Abstract][Full Text] [Related]
11. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
13. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
[TBL] [Abstract][Full Text] [Related]
14. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
[No Abstract] [Full Text] [Related]
15. Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis.
Takamori M
J Neuroimmunol; 2008 Aug; 200(1-2):142-4. PubMed ID: 18602703
[TBL] [Abstract][Full Text] [Related]
16. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
17. Contribution of anti-ryanodine receptor antibody to impairment of excitation-contraction coupling in myasthenia gravis.
Imai T; Tsuda E; Hozuki T; Yoshikawa H; Yamauchi R; Saitoh M; Hisahara S; Motomura M; Kawamata J; Shimohama S
Clin Neurophysiol; 2012 Jun; 123(6):1242-7. PubMed ID: 22136737
[TBL] [Abstract][Full Text] [Related]
18. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
Romi F; Skeie GO; Gilhus NE; Aarli JA
Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
[TBL] [Abstract][Full Text] [Related]
19. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
Takamori M; Motomura M; Kawaguchi N; Nemoto Y; Hattori T; Yoshikawa H; Otsuka K
Neurology; 2004 May; 62(10):1894-6. PubMed ID: 15159506
[TBL] [Abstract][Full Text] [Related]
20. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
